Key terms

About HIMS

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest HIMS news

Apr 16 5:02am ET Hims & Hers downgraded to Hold from Buy at Jefferies Apr 04 1:46pm ET Hims and Hers Health call volume above normal and directionally bullish Apr 03 4:32pm ET Hims & Hers Health Welcomes New Independent Director Apr 03 9:07am ET Hims & Hers appoints Payne as new board of director Mar 20 12:06pm ET Hims and Hers Health call volume above normal and directionally bullish Mar 06 8:45am ET Largest borrow rate increases among liquid names Feb 29 3:55pm ET Hims & Hers Health: A Strong Buy on Accelerated Growth and Market Positioning Feb 29 3:44pm ET Hims & Hers price target raised to $19 from $15 at Tigress Financial Feb 28 12:01am ET Analysts Conflicted on These Healthcare Names: ACADIA Pharmaceuticals (ACAD), Hims & Hers Health (HIMS) and Amylyx Pharmaceuticals Inc (AMLX) Feb 27 12:00pm ET Hims & Hers rises 34.4% Feb 27 10:00am ET Hims & Hers rises 25.3% Feb 27 9:47am ET Hims & Hers rises 20.2% Feb 27 9:13am ET Hims & Hers price target raised to $13 from $10 at Truist Feb 27 8:46am ET Hims & Hers price target raised to $14 from $8 at Deutsche Bank Feb 27 8:34am ET Hims & Hers price target raised to $17 from $15 at Guggenheim Feb 27 8:10am ET Analysts Are Bullish on Top Healthcare Stocks: Bruker (BRKR), Hims & Hers Health (HIMS) Feb 27 7:48am ET Truist Financial Reaffirms Their Hold Rating on Hims & Hers Health (HIMS) Feb 27 7:44am ET Hims & Hers Health (HIMS) Gets a Hold from Piper Sandler Feb 27 7:44am ET Hims & Hers price target raised to $14.50 from $12.50 at BofA Feb 27 6:55am ET Hims & Hers price target raised to $16 from $12 at Citi Feb 27 6:21am ET HIMS Earnings: Hims & Hers Skyrockets on Q4 Beat Feb 27 5:51am ET Hims & Hers Health: A Strong Buy on Accelerated Financial Goals and Operational Efficiency Feb 26 4:15pm ET Hims & Hers sees FY24 revenue $1.17B-$1.2B, consensus $1.1B Feb 26 4:14pm ET Hims & Hers sees Q1 revenue $267M-$272M, consensus $251.26M Feb 26 4:14pm ET Hims & Hers reports Q4 EPS 1c, consensus (2c) Feb 26 2:04pm ET Hims and Hers Health options imply 14.6% move in share price post-earnings Feb 26 6:22am ET Hims & Hers initiated with a Market Perform at Leerink

No recent press releases are available for HIMS

HIMS Financials

1-year income & revenue

Key terms

HIMS Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

HIMS Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms